Evaluating the Role of SNCA, LRRK2, and GBA in Chinese Patients with Early‐Onset Parkinson's Disease
Yongping Chen,Xiaojing Gu,Ruwei Ou,Lingyu Zhang,Yanbing Hou,Kuncheng Liu,Bei Cao,Qianqian Wei,Chunyu Li,Wei Song,Bi Zhao,Ying Wu,Jingqiu Cheng,Huifang Shang
DOI: https://doi.org/10.1002/mds.28191
IF: 9.698
2020-01-01
Movement Disorders
Abstract:Background Defects in the alpha-synuclein, leucine-rich repeat kinase 2, or glucocerebrosidase genes have been regarded as essential contributors to PD. However, genetic variability of these genes with respect to early-onset PD remains poorly defined for the Chinese demographic. Objectives We aim to systematically characterize the clinical and genetic architecture of alpha-synuclein, leucine-rich repeat kinase 2, and glucocerebrosidase in Chinese early-onset PD patients. Methods Whole-exome sequencing and Sanger sequencing were used to identify variants of alpha-synuclein, leucine-rich repeat kinase 2, and glucocerebrosidase in 662 Chinese early-onset PD patients. Haplotype and burden analyses were conducted to investigate the role of rare variants of these three genes in early-onset PD. Results Sixty rare variants, including 23 novel variants, were identified in 73 patients (11.0%). Frequencies of patients with rare pathogenic/likely pathogenic variants of alpha-synuclein, leucine-rich repeat kinase 2, and glucocerebrosidase were 0.6%, 3.0%, and 5.4%, respectively. Evidences of two founder events exclusive to Asians were identified in 2 patients with leucine-rich repeat kinase 2 p.R1441C and 3 patients with alpha-synuclein p.A53V. Gene-based burden analysis supported glucocerebrosidase as a strong risk factor for early-onset PD, but argued against over-representation of rare variants in alpha-synuclein or leucine-rich repeat kinase 2 in early-onset PD. Clinically, no differences in motor or nonmotor symptoms were found between glucocerebrosidase variants carriers, and noncarriers or between leucine-rich repeat kinase 2 carriers and noncarriers. Patients with alpha-synuclein variants showed both rapid progression and worse cognitive impairment. Conclusion Our study provides a better understanding of the clinical and genetic correlations of alpha-synuclein, leucine-rich repeat kinase 2, and glucocerebrosidase in early-onset PD, which may be beneficial for drafting genetic scanning strategies and evaluating disease progression. (c) 2020 International Parkinson and Movement Disorder Society